The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies.EBI
Momenta Pharmaceuticals
A focused sulfated glycoconjugate Ugi library for probing heparan sulfate-binding angiogenic growth factors.EBI
The University Of Queensland
Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis.EBI
Progen Pharmaceuticals
Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth.EBI
Progen Pharmaceuticals
Design, synthesis, FGF-1 binding, and molecular modeling studies of conformationally flexible heparin mimetic disaccharides.EBI
Progen Pharmaceuticals
Validation of molecular docking calculations involving FGF-1 and FGF-2.EBI
Progen Industries
Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88).EBI
Progen Industries
Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries.EBI
Progen Industries
Derivatives form better lipoxygenase inhibitors than piperine: in vitro and in silico study.BDB
Kannur University, Thalassery Campus